medicinal cannabis
- Home
- medicinal cannabis
Public
Research Note - Rise of the Cashless Economy
- Review
- June 3, 2020
Novatti launches new payments platform for purpose-issued Visa cards
- Review
- September 29, 2020
Latest Articles
Althea to launch low-cost cannabis as medicinal gateway option
If Australians have reservations about the use of medicinal cannabis to cure their ailments, there will soon be a low-cost option to trial cannabis products, with Althea Group (ASX: AGH) to launch a new range of low dosage oils to give first-time users an affordable entry point. The new ‘flexi’ cannabis oil products, as the
Read MorePublic
Epsilon Healthcare expands medicinal cannabis telehealth to in-clinic locations
Having developed a thriving telehealth business that has seen significant uptake from patients seeking medicinal cannabis solutions, Epsilon Healthcare (ASX: EPN) is set to expand into retail locations for in-clinic consultations. While the progressive healthcare provider moves in the opposite direction to other medical clinics which were forced to adopt telehealth during the pandemic, telehealth
Read MorePublic
ECS Botanics lines up UK and German customers for cannabis exports
Medicinal cannabis company ECS Botanics (ASX: ECS) is quickly growing its international sales pipeline following their acquisition of Murray Meds last month, securing UK pharmaceuticals company The Armour Group on a 3-year export deal. The agreement will be for the sale, export and distribution of medicinal cannabis products in the UK for clinical trials initially,
Read MorePublic
Emyria to register cannabinoid-based medicine targeting anxiety and depression
Pharmaceuticals company Emyria (ASX: EMD) is set to commence the regulatory process of registering their cannabinoid-based medicine EMD-003 as a treatment to reduce symptoms of mental health disorders, leveraging extensive data gathered from their network of clinics. Initial evidence collected by Emyria’s subsidiary Emerald Clinics has identified an unmet need by targeting the treatment of
Read MorePublic
Althea becomes first Aussie cannabis company to be licensed in Germany
Medicinal cannabis and research company Althea Group (ASX: AGH) has become the first Australian producer of commercial cannabis products to be granted the required licenses in Germany for sales and distribution. With the licences, Althea expects their first shipment of their Australian-made medicinal cannabis extract products to take place in December 2020. The licenses were
Read MorePublic
Health Insurer adds cannabis to coverage with Little Green Pharma partnership
Members of private health insurer Health Insurance Fund (HIF) will be given priority access to Little Green Pharma (ASX: LGP) and their research into medicinal cannabis with the two commencing a strategic partnership focused on improving patient quality of life. Under the partnership, HIF members will be given priority participation in Little Green Pharma product
Read MorePublic